An announcement from 4D Molecular Therapeutics ( ($FDMT) ) is now available. On November 6, 2025, 4D Molecular Therapeutics announced positive ...
EMERYVILLE, Calif., Oct. 13, 2025 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT, or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback